Prediction of Human Dihydroorotate Dehydrogenase Inhibitor Activity by a Weighted Average Ensemble-Based Prediction
Abstract
Keywords
Kaynakça
- Ganga, G.K.: Accelerating drug discovery targeting dihydroorotate dehydrogenase using machine learning and generative AI approaches. Comput Biol Chem, 118, 2025, p. 108443.
- Kawatani, M. et al.: Identification of a dihydroorotate dehydrogenase inhibitor that inhibits cancer cell growth by proteomic profiling. Oncol Res, 31 (6), 2023, p. 833.
- Leban, J. et al.: Discovery of a novel series of DHODH inhibitors by a docking procedure and QSAR refinement. Bioorg Med Chem Lett, 14 (1), 2004, p. 55–58.
- Aqeel, I. et al.: Hybrid Approach to Identifying Druglikeness Leading Compounds against COVID-19 3CL Protease. Pharmaceuticals, 15 (11), 2022, p. 1333.
- Mendez, D. et al.: ChEMBL: towards direct deposition of bioassay data. Nucleic Acids Res, 47 (D1), 2019, p. D930–D940.
- Atasever, S.: Enhancing HCV NS3 Inhibitor Classification with Optimized Molecular Fingerprints Using Random Forest. Int J Mol Sci, 26 (6), 2025, p. 2680.
- Yang, J. et al.: Concepts and applications of chemical fingerprint for hit and lead screening. Drug Discov Today, 27 (11), 2022, p. 103356.
- Xie, L. et al.: Improvement of prediction performance with conjoint molecular fingerprint in deep learning. Front Pharmacol, 11, 2020, p. 606668.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Bilgi Sistemleri (Diğer) , Biyomedikal Mühendisliği (Diğer)
Bölüm
Araştırma Makalesi
Yayımlanma Tarihi
30 Aralık 2025
Gönderilme Tarihi
10 Ekim 2025
Kabul Tarihi
8 Aralık 2025
Yayımlandığı Sayı
Yıl 2025 Cilt: 14 Sayı: 4